Veteran Journalist Itai Zilber Undergoes Successful Liver Cancer Surgery
Translated & summarized from Ice by baba
Israeli journalist Itai Zilber, Content Development Manager for Galatz, successfully underwent surgery to remove a two-centimeter liver tumor. Post-operative scans revealed no further evidence of cancer, but Zilber will return to treatment in two to three weeks due to his chronic condition and fear of a fourth recurrence. The minimally invasive surgery was performed laparoscopically.
The story in 5 lines · by baba
- Journalist Itai Zilber had successful surgery to remove a liver tumor.
- Post-surgery scans showed no additional cancer findings.
- Zilber will resume cancer treatments in two to three weeks.
- Doctors fear a potential fourth recurrence of the disease.
- The tumor was two centimeters and removed via minimally invasive surgery.
Itai Zilber, Content Development Manager for the Israeli radio station Galatz, revealed on Tuesday that he underwent surgery to remove a cancerous tumor from his liver. Zilber, who has been battling cancer and describes himself as a chronic patient, shared that the operation was successful and post-surgery examinations showed no additional findings. Despite the positive news, he anticipates returning to treatment soon due to concerns about a potential fourth recurrence of the disease.
Zilber updated his followers, stating that his surgeon was very pleased with the outcome. The tumor, approximately two centimeters in diameter, was located on the left lobe of his liver. Its size and position allowed for a minimally invasive laparoscopic procedure, involving four small incisions rather than a large abdominal opening.
"The surgery was relatively easy thanks to the tumor's size (about two cm) and its location on the edge of the left liver," Zilber wrote. "The surgery was performed laparoscopically, meaning they didn't make an incision in the abdomen but entered through four small wounds."
Although the tumor was removed successfully, Zilber's medical journey continues. He plans to rest for a short period but expects to resume treatments in two to three weeks. This decision stems from his chronic condition and history with the illness, with doctors concerned about the cancer returning for a fourth time.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Right 1Other 1
